
BioHarvest Sciences (BHST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
BioHarvest Sciences (BHST) last issued guidance on August 11, 2026 for fiscal year 2026. The company guided revenue in the range of $37M - $40M for the period.
Compared to prior guidance, BioHarvest Sciences lowered its revenue forecast from a prior range of $42M - $48M.
BioHarvest Sciences has issued 4 guidance updates between November 13, 2025 and August 11, 2026. During this period, the company raised its outlook 1 time and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.12 | $-0.10 | $-0.12 |
| Actual | $-0.17 | $-0.11 | $-0.10 | $-0.14 |
| Surprise | -41.7% | +8.33% | 0.00% | -16.7% |
| Revenue | ||||
| Estimate | $9.5M | $8.8M | $9.3M | $9.1M |
| Actual | $8.8M | $8.5M | $9.1M | $9.1M |
| Surprise | -7.34% | -3.37% | -1.93% | -0.61% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.12 | $-0.17 | $-0.15 |
| Revenue | ||||
| Consensus | $9.2M | $10.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.17 | $-0.12 | -41.7 % |
| Q1 | May 14, 2026 | $-0.11 | $-0.12 | 8.33 % |
| Q4 | Mar 31, 2026 | $-0.10 | $-0.10 | 0.00 % |
| Q3 | Nov 13, 2025 | $-0.14 | $-0.12 | -16.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $8.84M | $9.54M | -7.34 % |
| Q1 | May 14, 2026 | $8.50M | $8.80M | -3.37 % |
| Q4 | Mar 31, 2026 | $9.10M | $9.28M | -1.93 % |
| Q3 | Nov 13, 2025 | $9.07M | $9.12M | -0.61 % |